AAPG
Ascentage Pharma Group International
14.90$
+0.0%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.4% | – | – | 14.4% | 15.8% | 11.9% | 10.5% | 13.8% | 3.0% | 23.6% | |
| 96.6% | 100.0% | 100.0% | 85.6% | 84.2% | 88.1% | 89.5% | 86.2% | 97.0% | 76.4% | |
| 1,339.4% | 1,877.6% | 3,666.3% | 3,196.3% | 4,534.7% | 2,746.3% | 354.3% | 318.5% | 96.6% | 194.0% | |
| 231.0% | 211.8% | 1,310.7% | 681.1% | 503.5% | 514.2% | 81.3% | 81.6% | 19.1% | 107.4% | |
| 1,591.6% | 2,164.9% | 4,896.9% | 4,100.5% | 5,417.1% | 3,431.6% | 494.7% | 479.3% | 134.7% | 287.6% | |
| -1,495.0% | -2,064.9% | -5,074.8% | -4,014.9% | -5,332.9% | -3,116.6% | -405.2% | -393.1% | -37.7% | -211.1% | |
| 42.5% | 915.6% | 542.4% | 29.4% | 50.2% | 59.9% | 25.2% | 43.3% | 6.6% | 9.4% | |
| -1,406.5% | -1,898.2% | -5,295.1% | -10,213.7% | -5,425.3% | -2,981.9% | -423.0% | -420.2% | -40.3% | -215.3% | |
| – | -25.3% | -23.5% | -11.0% | 17.3% | -178.5% | -2.0% | -3.2% | 1.1% | 1.2% | |
| -1,406.5% | -1,872.9% | -5,072.8% | -10,202.7% | -5,442.6% | -2,803.4% | -421.0% | -417.0% | -41.3% | -216.5% | |
| -1,516.0% | -785.0% | -4,793.0% | -10,157.9% | -5,238.8% | -2,860.4% | -375.3% | -335.0% | -24.2% | -196.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.